DDR2 and neoplasm: In our in vivo study, we show a decrease in tumor burden in mice injected with DDR2-depleted CAFs (CAF shDDR2 + ES2) had decreased tumor burden compared to mice injected with DDR2-expressing CAFs (CAF shSCRM + ES2).